[1]詹秀娥 乔彩萍.赖诺普利与氨氯地平对老年性高血压患者左心室质量及舒张功能影响的Meta分析[J].内科,2014,(03):270-274,291.
 ZHAN Xiu-e,QIAO Cai-ping.The meta-analysis of the effects of lisinopril versus amlodipine on left ventricular mass and diastolic function in elderly patients with hypertension[J].Internal Medicine of China,2014,(03):270-274,291.
点击复制

赖诺普利与氨氯地平对老年性高血压患者左心室质量及舒张功能影响的Meta分析()
分享到:

《内科》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2014年03期
页码:
270-274,291
栏目:
论著
出版日期:
2014-06-30

文章信息/Info

Title:
The meta-analysis of the effects of lisinopril versus amlodipine on left ventricular mass and diastolic function in elderly patients with hypertension
文章编号:
1673-7768(2014)03-0270-06
作者:
詹秀娥 乔彩萍
甘肃省中医院白银分院,白银市730900
Author(s):
ZHAN Xiu-e QIAO Cai-ping
Baiyin Branch of Gansu Provincial Hospital of Traditional Chinese Medicine, Baiyin 730900, China
关键词:
赖诺普利氨氯地平高血压左心室肥厚Meta分析
Keywords:
Lisinopril Amlodipine Hypertension Left ventricular hypertrophyMeta analysis
分类号:
R 544;R 541.3
文献标志码:
A
摘要:
目的系统评价赖诺普利与氨氯地平对老年性高血压患者左心室质量及舒张功能的影响。方法计算机检索Cochrane Library、Pubmed、EMBASE、中国学术期刊网络出版总库、中国生物医学文献数据库、维普、万方,从各数据库建库至2012年11月,纳入赖诺普利与氨氯地平治疗老年性高血压的RCT文献,按纳入与排除标准选择文献并评价质量后,用Revman 5.1软件进行Meta分析。结果共纳入4篇随机对照试验,408例患者。Meta分析结果显示:赖诺普利与氨氯地平在减小左室心肌重量指数[MD=-9.79 95%CI(-27.70,8.12),P=0.28]、左室舒张末期内径[MD=0.22 95%CI(-1.57,2.01),P=0.81]、舒张期室间隔厚度[MD=-0.94 95%CI(-3.16,1.27),P=0.40]、左心室后壁厚度[MD=-1.689 5%CI(-4.82,1.45),P=0.29]、左心室质量[MD=-6.64 95%CI(-15.84,2.56),P=0.16]、收缩压[MD=0.42 95%CI(-2.41,3.25),P=0.77]、舒张压[MD=0.80 95%CI(-1.13,2.73),P=0.42]方面的差异无统计学意义。而在增加E/A比值[MD=0.07 95%CI(0.00,0.13),P=0.04]方面,氨氯地平优于赖诺普利。结论赖诺普利与氨氯地平在减少左心室质量,提高舒张功能方面的差异并不明显。但从药品经济学观点考虑,赖诺普利具有更好的成本-效果比。
Abstract:
ObjectiveTo systematically evaluate the effectiveness and safety of lisinopril and amlodipine on left ventricular mass and diastolic function in elderly patients with hypertension. MethodsCochrane library, PubMed,EMBASE,CNKI,CBM,VIP and WangFang Datebase were selected to search the randomized controlled trials that compared lisinopril with amlodipine in the treatment of hypertension from initiation establishment of database to November, 2012. The quality of the included studies were evaluated according to the predefined inclusion and exclusion criteria and then meta-analysis was conducted by using RevMan 5.1 software. ResultsA total of 4 randomized controlled trials (408 patients) were included. Meta-analysis results suggested that there were no significant differences in left ventricular mass index(MD=-9.79 95%CI-27.70 to 8.12),left ventricular end diastolic diameter(MD=0.22 95%CI-1.57 to 2.01),interventricular septal thickness(MD=-0.94 95%CI-3.16 to 1.27),left ventricular posterior wall thickness(MD=-1.68 95%CI-4.82 to 1.45),left ventricular mass (MD=-6.64 95%CI-15.84 to 2.56),systolic pressure(MD= 0.42 95%CI -2.41 to 3.25) and diastolic pressure(MD=0.80 95%CI -1.13 to 2.73) between lisinopril and amlodipine group. But for E/A(MD=0.07 95%CI 0.00 to 0.13), amlodipine was superior to lisinopril. ConclusionsThe effectiveness of lisinopril and amlodipine on left ventricular mass and diastolic function in elderly patients with hypertensive have no significant difference. But in consideration of the cost,lisinopril has a better cost-effectiveness ratio.

参考文献/References:

[1]张若兰,郝玉明.老年性高血压诊治进展[J].河北医科大学学报,2008,29(2):313-316.
[2]Katlloii RE,Couri DM.left ventricular hypertrophy:major risk factor in patients with hypertension.update and practical clinical applications[J].Int hypertension,2011,187(6):1-10.
[3]刘国仗.高血压左室肥厚与逆转[J].中国循环杂志,1993,8(12):707.
[4]赵国忠,冯小兰.联用氨氯地平与吲达帕胺治疗高血压病逆转左室肥厚的疗效观察[J].浙江临床医学,2004,6(1):35-36.
[5]丁国锋,孙运爱,武全莲,等.氨氯地平治疗高血压及逆转左心室肥厚作用的治疗研究[J].心血管康复医学杂志,2004,13(2):35.
[6]白民刚,谷刚,朴德成,等.赖诺普利和氨氯地平逆转原发性高血压左室肥厚的对比研究[J].实用临床医药杂志,2003,7(4):360-361.
[7]聂祥碧,万嘉豫,蒋晓梅,等.长期服用氨氯地平对老年高血压左室肥厚的影响[J].贵州医药,2001,25(2):138-139.
[8]Beltman FW,Heesen WF,Smit AJ,et al.Effects of amlodipine and lisinopril on left ventricular mass and diastolic function in previously untreated patients with mild to moderate diastolic hypertension[J].Blood press,1998,7(2):109-117.
[9]Terpstra WF1,May JF,Smit AJ,et al.Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly,previously untreated hypertensive patients: the ELVERA trial[J].J Hypertens,2001,19(2):303-309.
[10]郭艺芳,张倩辉.2009版欧洲高血压指南解读[J].中华高血压杂志,2009,(12):7-8.
[11]Kannel WB.Left ventricular hypertrophy as a risk factor:the Framingham experience[J].J Hypertens-suppl,1991,9(2):3-8.
[12]刘新民.实用临床药典[M].长春:辽宁科学技术出版社,2003:245-251. [13]郑三晖.氨氯地平和厄贝沙坦对老年高血压左室肥厚和Q-T离散度的影响[J].广东医学,2006,27(5):749-750.
[14]唐丽霞.三种长效降压药物治疗方案的最小成本分析[J].药物流行病学杂志,2006,15(4):244-245.

相似文献/References:

[1]甘毅峰 黎妙妮.氨氯地平治疗妊娠合并高血压40例疗效分析[J].内科,2013,(04):356.
 [J].Internal Medicine of China,2013,(03):356.
[2]王丽梅,张彩兰,史继娥.缬沙坦联合氨氯地平治疗高血压合并糖尿病临床观察[J].内科,2015,(06):887.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.06.47]
 [J].Internal Medicine of China,2015,(03):887.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.06.47]
[3]朱敏,吴启兴.贝那普利联合氨氯地平治疗难治性高血压临床分析[J].内科,2016,(04):595.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2016.04.30]
 [J].Internal Medicine of China,2016,(03):595.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2016.04.30]
[4]许峰,梁科,赵伟,等.瑞舒伐他汀联合氨氯地平治疗对老年高血压合并颈动脉粥样硬化患者的血压及动脉硬化的影响▲[J].内科,2017,12(06):796.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2017.06.22]
 [J].Internal Medicine of China,2017,12(03):796.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2017.06.22]
[5]柳要伟.厄贝沙坦联合氨氯地平治疗对高血压患者肾功能及肾小管功能的影响[J].内科,2018,13(01):72.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2018.01.23]
 [J].Internal Medicine of China,2018,13(03):72.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2018.01.23]

备注/Memo

备注/Memo:
(收稿日期:2014-03-11修回日期:2014-05-08)
更新日期/Last Update: 2015-10-15